2024年7月7日
479633-63-1,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-impurity-r.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:13:30 2024-07-07 00:13:30 Tofacitinib Impurity R CAS号 479633-63-1 2024年7月7日
179688-26-7,Erlotinib
https://www.watson-int.cn/wp-content/uploads/2024/07/erlotinib-impurity-11.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:13:30 2024-07-07 00:13:30 Erlotinib Impurity 11 CAS号 179688-26-7 2024年7月7日
236750-65-5,Erlotinib
https://www.watson-int.cn/wp-content/uploads/2024/07/erlotinib-impurity-18.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:13:30 2024-07-07 00:13:30 Erlotinib Impurity 17 CAS号 236750-65-5 2024年7月7日
126150-57-0,Docetaxel
https://www.watson-int.cn/wp-content/uploads/2024/07/docetaxel-impurity-13.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:13:30 2024-07-07 00:13:30 Docetaxel Impurity 13 CAS号 126150-57-0 2024年7月7日
146924-91-6,Docetaxel
https://www.watson-int.cn/wp-content/uploads/2024/07/docetaxel-impurity-15.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:13:30 2024-07-07 00:13:30 Docetaxel Impurity 15 CAS号 146924-91-6 2024年7月7日
66147-29-3,Methotrexate
https://www.watson-int.cn/wp-content/uploads/2024/07/methotrexate-ep-impurity-i.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:13:30 2024-07-07 00:13:30 Methotrexate EP Impurity I CAS号 66147-29-3 2024年7月7日
2295-31-0,Pioglitazone
https://www.watson-int.cn/wp-content/uploads/2024/07/24-thiazolidinedione.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:12:58 2024-07-07 00:12:58 2,4-Thiazolidinedione CAS号 2295-31-0 2024年7月7日
1206550-99-3,Febuxostat
https://www.watson-int.cn/wp-content/uploads/2024/07/febuxostat-descyano-impurity.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:12:58 2024-07-07 00:12:58 Febuxostat Descyano Impurity CAS号 1206550-99-3 2024年7月7日
7210-77-7,Febuxostat
https://www.watson-int.cn/wp-content/uploads/2024/07/febuxostat-dimethylthiazole-ethyl-ester-impurity.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:12:58 2024-07-07 00:12:58 Febuxostat Dimethylthiazole Ethyl Ester Impurity CAS号 7210-77-7 2024年7月7日
1335202-59-9,Febuxostat
https://www.watson-int.cn/wp-content/uploads/2024/07/febuxostat-sec-butyl-ether-acid-impurity.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:12:58 2024-07-07 00:12:58 Febuxostat USP Related Compound D CAS号 1335202-59-9
Scroll to top
Scroll to top
Scroll to top